University of Kansas Voice and Swallow Center Director, David Garnett MD, FACS delivers keynote presentation in China: "Hyperacidity and the Irritated Airway"
Andrew Krauss, MS, CCC-SLP is heading to Philly to represent Restech at the Voice Foundation's Annual Symposium. This meeting is an intimate gathering of voice professionals, researchers, and students in otolaryngology, voice science, speech pathology and vocal pedagogy. Restech has supported the meeting for the past decade and we are excited to be there again this year.
Dr. Josef Schlömicher-Thier
Chief of the International Voice Center Austria
Chief of the ENT Center in Neumarkt/Salzburg
CASE HISTORY & EVALUATION
A 60 year old male presented with hoarseness, a heavy cough, and voice problems extending back at least four years. Symptoms had recently exacerbated leaving the individual out of work on sick leave. The patient reported multiple prior pneumonias, but presented with a normal pulmonary exam at the time of the initial assessment.
Prior to his office assessment, the patient was examined at a different hospital. This included the discovery of a minor hiatal hernia, which was accompanied by a negative esophageal manometry test and a negative duel channel pH test. Video Stroboscopy revealed hyperplasia/ leucoplakia. VRP showed a restricted mass.
Houston, TX, 04/24/18: Respiratory Technology Corporation (Restech) announced today the asset acquisition of Mederi Therapeutics Inc. In response to the increasing need for therapeutic options to address the growing conditions of reflux disease and gastric disease, Restech welcomes the addition Stretta® and Secca® technology to their product portfolio. These new innovative product lines complement Restech’s existing diagnostic devices with therapeutic solutions, provide additional clinical pathways, and broaden Restech’s global distribution network.
Commonly referred to as “silent reflux,” laryngopharyngeal reflux (LPR) has long been difficult for physicians to diagnose because of its nonspecific symptoms. The traditional approach to assessing LPR symptoms relies on response to empiric treatment and symptom improvement using the reflux symptom index (RSI) or reflux finding score (RFS). Without clear criteria in place, these tools are highly subjective.
By: Craig H. Zalvan, MD, FACS
Chief of Otolaryngology and Medical Director
The Institute for Voice and Swallowing Disorders
CASE HISTORY & EVALUATION
66 year old male presents with diagnosis of GERD and asthma for chronic cough. He reports being well until 5 years ago when he had a severe URI, symptoms of which resolved, except for a chronic cough. Additional symptoms of ongoing waterbrash, throat clearing, and globus sensation; a tickle sensation in the throat followed by spasms of coughing associated with bouts of “wheezing,” described as a high pitch sound when breathing inward. He also reports his eyes tearing, rhinorrhea, and vocal strain with occasional bouts of nausea. Cold air and talking trigger coughing episodes.
Heartburn and regurgitation are easily identifiable symptoms of gastroesophageal reflux disease (GERD) and tend to be easier to treat with PPI therapy. However, symptoms of laryngopharyngeal reflux (LPR) or atypical reflux have become very prevalent in the population since they are difficult to spot and are often unresponsive to PPI therapy.
EXPANDING pH MEASUREMENT CAPABILITIES
The Dx–pH Measurement System is a revolutionary device that comfortably measures pH in the upper airway or esophagus. Prior to Restech’s introduction, it was difficult to detect reflux in the upper airway because previously available pH monitors were limited to measuring liquid reflux in the esophagus. Restech’s patented technology is the only commercial device available that is capable of measuring both liquid and aerosolized pH levels.
Your doctor will always be the best resource for strategies to tackle reflux. Have your symptoms been evaluated by a professional? Use our physician finder to locate a Restech provider near you.
In the meantime, here are some simple dietary and lifestyle modifications for reflux that can make a world of difference.
Restech’s pH system was the highlight of new research presented by Dr. Ezra Teitelbaum at the 2017 American College of Surgeons’session on Novel Endoscopic and Minimally Invasive Techniques for Esophageal Dysmotility and Reflux Disease. Dr. Teitelbaum (Assistant Professor of Surgery and Medical Education at Northwestern University) collaborated with Dr. Steven DeMeester (President and Executive Director of the Foundation for Research and Education in Esophageal and Foregut Disorders) on a study comparing the results of different pH monitoring tests in patients off antisecretory medications.